Ambea AB (publ) (STO:AMBEA)
Sweden
· Delayed Price · Currency is SEK | Market Cap | 11.49B |
| Revenue (ttm) | 16.11B |
| Net Income (ttm) | 665.00M |
| Shares Out | 82.10M |
| EPS (ttm) | 7.92 |
| PE Ratio | 17.68 |
| Forward PE | 13.26 |
| Dividend | 2.65 (1.92%) |
| Ex-Dividend Date | May 13, 2026 |
| Volume | 136,268 |
| Average Volume | 111,373 |
| Open | 139.10 |
| Previous Close | 137.70 |
| Day's Range | 138.00 - 142.00 |
| 52-Week Range | 104.90 - 143.60 |
| Beta | 0.67 |
| RSI | 63.32 |
| Earnings Date | Mar 31, 2026 |
About Ambea AB
Ambea AB (publ) provides elderly care, disability care, and psychosocial support for the elderly and people with disabilities in Sweden, Norway, and Denmark. It operates through Nytida, Vardaga, Stendi, Altiden, and Klara segments. The company offers social care services; schools for children and youth with neuropsychiatric disorders under the Nytida brand; nursing homes and home care services for elderly people under the Vardaga brand; and social care for adults, children, and youth, as well as personal assistance under the Stendi brand. It al... [Read more]
Financial Performance
In 2025, Ambea AB's revenue was 16.11 billion, an increase of 12.88% compared to the previous year's 14.28 billion. Earnings were 665.00 million, an increase of 7.26%.
Financial StatementsNews
Ambea AB (FRA:6MA) Q4 2025 Earnings Call Highlights: Strong Sales Growth Amidst Strategic ...
Ambea AB (FRA:6MA) Q4 2025 Earnings Call Highlights: Strong Sales Growth Amidst Strategic Investments
Q4 2025 Ambea AB (publ) Earnings Call Transcript
Q4 2025 Ambea AB (publ) Earnings Call Transcript
Ambea AB Earnings Call Transcript: Q4 2025
Q4 2025 saw 15% net sales growth, strong cash flow, and continued investments in leadership, IT, and M&A, notably the Validia acquisition. Margins were impacted by integration and startup costs, but financial targets remain intact, with a 20% dividend increase proposed.
What To Expect From Ambea AB (OSTO:AMBEA) Q4 2025 Earnings
What To Expect From Ambea AB (OSTO:AMBEA) Q4 2025 Earnings
Ambea AB (STU:6MA) Q3 2025 Earnings Call Highlights: Strong Sales Growth and Strategic Expansions
Ambea AB (STU:6MA) Q3 2025 Earnings Call Highlights: Strong Sales Growth and Strategic Expansions
Q3 2025 Ambea AB (publ) Earnings Call Transcript
Q3 2025 Ambea AB (publ) Earnings Call Transcript
Ambea AB Earnings Call Transcript: Q3 2025
Q3 2025 saw robust growth with net sales up 16% and EBITDA up 19%, driven by acquisitions and organic expansion. Margin and cash flow targets were exceeded, and the company strengthened its Nordic presence, especially in Finland, while launching a major share buyback.
Ambea AB Earnings Call Transcript: Q2 2025
Net sales grew 16% year-over-year, driven by acquisitions and organic growth, with all financial targets met for the first time. Segment performance was strong across the Nordics, and further M&A and organic expansion are expected, especially in Finland and Denmark.
Ambea AB Earnings Call Transcript: Q1 2025
Q1 2025 saw 5% net sales growth and a 10% rise in EBITDA, driven by organic expansion and acquisitions, notably Validia in Finland. Segment performance was strong overall, with some margin pressure in Nutida, and robust cash flow supported dividends, M&A, and buybacks.
Ambea AB Transcript: M&A Announcement
The acquisition of Validia provides a strategic entry into Finland, expanding the group’s Nordic footprint and offering a platform for future growth. Financial terms include a EUR 126 million enterprise value, limited cost synergies, and integration by 2026. Seller retains a stake, supporting ongoing alignment.
Ambea AB Earnings Call Transcript: Q4 2024
Q4 2024 saw 7% net sales growth and a 20% EBITDA increase, with strong operational improvements and robust cash flow. Segment performance was solid, especially in Vardaga and Altiden, and the company remains well below leverage targets while pursuing further acquisitions.
Ambea AB Earnings Call Transcript: Q3 2024
Q3 2024 saw 6% net sales growth and a 25% EBITDA increase, driven by higher occupancy, new contracts, and acquisitions. Strong cash flow supported dividends, buybacks, and debt reduction, while new Danish legislation and ongoing pipeline expansion position the group for future growth.
Ambea AB (FRA:6MA) Q2 2024 Earnings Call Transcript Highlights: Strong EBITDA Growth and ...
Ambea AB (FRA:6MA) Q2 2024 Earnings Call Transcript Highlights: Strong EBITDA Growth and Strategic Share Buybacks
Q2 2024 Ambea AB (publ) Earnings Call Transcript
Q2 2024 Ambea AB (publ) Earnings Call Transcript
Ambea AB Earnings Call Transcript: Q2 2024
Q2 2024 saw 6% net sales growth and a 42% EBITDA increase, with strong performance in Vardaga and Stendi, while Altiden and Klara lagged. Free cash flow and margins improved, supporting dividends, acquisitions, and share buybacks. Growth is expected to continue, driven by demand, new units, and M&A.